financetom
Business
financetom
/
Business
/
US produces most uranium since 2018, EIA says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US produces most uranium since 2018, EIA says
Apr 2, 2025 9:26 AM

NEW YORK, April 2 (Reuters) - The U.S. produced more

uranium concentrate, which is used to fuel nuclear reactors, in

the last three months of 2024 than it had in any quarter in the

last six years, the U.S. Energy Information Administration said

on Wednesday.

Higher prices of uranium and the resumption of production at

the White Mesa Mill in Utah, which is the country's only active

uranium mill, spurred the output increase, the EIA said in a

report.

WHY IT'S IMPORTANT

The rise of U.S. electricity demand brought by data centers,

onshored manufacturing and the electrification of transportation

and buildings has renewed interest in power supplied by the

country's long-struggling nuclear energy industry.

Companies are now in the process of attempting to restart two

fully shut nuclear reactors, including one at the former Three

Mile Island facility. In an effort to kick-start the domestic

supply chain for nuclear power, the federal government offered

contracts to six companies to make uranium fuel late last year.

BY THE NUMBERS

Output of the concentrate totaled 375,401 pounds in the

fourth quarter of last year, which was higher than the total

production for each of the three prior years, the EIA said. The

supply, most of which came from two processing facilities in

Texas and Wyoming, was more than triple what was produced in the

third quarter of 2024, which totaled 121,296 pounds.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ionis Says Olezarsen Meets Primary Endpoint in Phase 3 Trials in Severe Hypertriglyceridemia
Ionis Says Olezarsen Meets Primary Endpoint in Phase 3 Trials in Severe Hypertriglyceridemia
Nov 10, 2025
07:18 AM EST, 11/10/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said over the weekend that two phase 3 studies of olezarsen in people with severe hypertriglyceridemia met the primary endpoint. The drug reduced fasting triglyceride levels by up to 72% at six months, and 86% of treated patients achieved triglyceride levels below the risk threshold for acute pancreatitis,...
Ex-Glencore employees plead not guilty to UK bribery charges ahead of 2027 trial
Ex-Glencore employees plead not guilty to UK bribery charges ahead of 2027 trial
Nov 10, 2025
LONDON, Nov 10 (Reuters) - Four ex-Glencore ( GLCNF ) oil traders on Monday pleaded not guilty in a London court to bribery charges ahead of their trial in 2027. Paul Hopkirk, Ramon Labiaga, David Perez and Martin Wakefield pleaded not guilty to charges of conspiring to give corrupt payments relating to Glencore's ( GLCNF ) operations in Nigeria, Cameroon...
Starwood Property Q3 revenue beats estimates
Starwood Property Q3 revenue beats estimates
Nov 10, 2025
Overview * Starwood Q3 revenue beats analyst expectations, adjusted net income misses estimates * Company invested $4.6 bln in Q3, including $2.2 bln in triple net lease investments * Raised $2.3 bln of capital across equity, term loan B, and high yield markets Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers *...
Ironwood Pharmaceuticals beats Q3 revenue estimates, raises outlook
Ironwood Pharmaceuticals beats Q3 revenue estimates, raises outlook
Nov 10, 2025
Overview * Ironwood Q3 2025 revenue rises 33% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 2025 beats estimates, reflecting strong operational performance * Company raises full-year 2025 guidance for LINZESS U.S. net sales and adjusted EBITDA Outlook * Ironwood raises 2025 LINZESS U.S. net sales guidance to $860 - $890 mln * Company increases 2025 total revenue guidance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved